Any current/future new fundraising through debt or equity?

There is no mention of any current or planned new fundraising through debt or equity in the transcript. The management did not indicate any immediate plans for incremental capital raising. When asked about capacity use for hydrogen cylinders, Puneet Khurana mentioned only minimal capex might be needed, implying limited new funding for capex. No discussion on equity dilution or new debt issuance was covered during the Q&A or closing remarks. Overall, the company appears focused on utilizing existing capacities and operational efficiencies rather than raising fresh funds at this time.

Any current/future capex/capital investment/strategic investment?

Existing capacity for CNG cylinders can be utilized to manufacture hydrogen cylinders with minimal incremental capex. No significant additional capex currently required for hydrogen cylinder production, but some minimal capex may be done. Egypt plant expansion is ongoing with construction expected to conclude by March 31, 2025. Revenues from Egypt plant are expected starting Q1 FY26; costs related to Egypt expansion will be capitalized, not operational expenses. The company is working towards scaling revenues and aims to reach Rs. 2,000 crore in the longer run, implying ongoing investments. F

Future growth expectations in sales/revenue/volumes?

The company expects overall volume growth of around 10%-15% in the coming years. Revenue growth guidance for FY25 and FY26 is also around 10%-15%. EBITDA margin guidance remains in double digits, targeting approximately 15%. The commercial vehicle (CV) segment, after facing a slowdown, is showing signs of recovery with an expected uptick. Market share expansion is a focus, with plans to add marquee customers, especially in the passenger vehicle (PV) segment. The hydrogen cylinder segment is expected to start contributing revenues in 2-3 years, representing a potential future growth a

Future growth expectations in earnings/operating earnings/profits/EPS?

Volume growth for FY24 was 18%, with expectations of 10%-15% volume growth going forward. Revenue growth guidance for FY25 and FY26 is around 10%-15%. EBITDA margin guidance is in the double-digit range, with a target around 15%. Management aims to sustain current margins and work towards margin improvement through product mix, cost savings, and operational efficiency. Hydrogen-related cylinder production may start in 2-3 years, offering a future growth avenue. Capacity expansion, including the Egypt plant commissioning by March 2025, is expected to contribute to future revenue. Improved marke

Current/ Expected Orderbook/ Pending Orders?

The USA business has a strong and large order book. Executable time period for the USA order book is around 18 months maximum. Orders come predominantly from large government organizations such as Army, Navy, and NASA. Exact order book value details were not provided but can be shared later by the management. Egypt plant is under construction and expected to commission by March 31, 2025, with revenues starting from Q1 FY26. Inventory levels increased to around Rs. 200 crore mainly due to pulled-up orders, with some finished goods dispatched recently. UAE business faced some dispatch delays due

IN US

Sale is live|00:00:00left today

Everest Kanto Cylinder LtdQ1 FY24Industrial Manufacturing

Everest Kanto Cylinder Ltd Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹123P/E: 10.9Market Cap: ₹1.3K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→The company expects overall volume growth of around 10%-15% in the coming years.
→Revenue growth guidance for FY25 and FY26 is also around 10%-15%.
→EBITDA margin guidance remains in double digits, targeting approximately 15%.
→The commercial vehicle (CV) segment, after facing a slowdown, is showing signs of recovery with an expected uptick.
→Market share expansion is a focus, with plans to add marquee customers, especially in the passenger vehicle (PV) segment.
→The hydrogen cylinder segment is expected to start contributing revenues in 2-3 years, representing a potential future growth avenue.
→Capacity expansion in Egypt is expected to start generating revenue from Q1 FY26 onwards.
→The company anticipates sustainable current margin levels with a possibility to improve margins depending on product mix and operational efficiencies.

Margin guidance

Category 3

→Volume growth for FY24 was 18%, with expectations of 10%-15% volume growth going forward.
→Revenue growth guidance for FY25 and FY26 is around 10%-15%.
→EBITDA margin guidance is in the double-digit range, with a target around 15%.
→Management aims to sustain current margins and work towards margin improvement through product mix, cost savings, and operational efficiency.
→Hydrogen-related cylinder production may start in 2-3 years, offering a future growth avenue.
→Capacity expansion, including the Egypt plant commissioning by March 2025, is expected to contribute to future revenue.
→Improved market share and sales in CNG and industrial segments are anticipated.
→Operating leverage expected from cost control on purchase price and plant efficiency improvements.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no mention of any current or planned new fundraising through debt or equity in the transcript.
→The management did not indicate any immediate plans for incremental capital raising.
→When asked about capacity use for hydrogen cylinders, Puneet Khurana mentioned only minimal capex might be needed, implying limited new funding for capex.
→No discussion on equity dilution or new debt issuance was covered during the Q&A or closing remarks.
→Overall, the company appears focused on utilizing existing capacities and operational efficiencies rather than raising fresh funds at this time.

Order book

Yes

→The USA business has a strong and large order book.
→Executable time period for the USA order book is around 18 months maximum.
→Orders come predominantly from large government organizations such as Army, Navy, and NASA.
→Exact order book value details were not provided but can be shared later by the management.
→Egypt plant is under construction and expected to commission by March 31, 2025, with revenues starting from Q1 FY26.
→Inventory levels increased to around Rs. 200 crore mainly due to pulled-up orders, with some finished goods dispatched recently.
→UAE business faced some dispatch delays due to foreign exchange issues but product movement and order executions are now resuming steadily.
→Overall, the company is optimistic about growth with capacities and a strong balance sheet to capitalize on opportunities.

Capex plans

Yes

→Existing capacity for CNG cylinders can be utilized to manufacture hydrogen cylinders with minimal incremental capex.
→No significant additional capex currently required for hydrogen cylinder production, but some minimal capex may be done.
→Egypt plant expansion is ongoing with construction expected to conclude by March 31, 2025.
→Revenues from Egypt plant are expected starting Q1 FY26; costs related to Egypt expansion will be capitalized, not operational expenses.
→The company is working towards scaling revenues and aims to reach Rs. 2,000 crore in the longer run, implying ongoing investments.
→Focus remains on capacity utilization improvements and expanding product mix across CNG, industrial, and jumbo cylinders segments.

How does Everest Kanto Cylinder Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1Everest Kanto Cylinder Ltd

Rev 3Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Everest Kanto Cylinder Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio